Related Experiment Video
Updated: Nov 21, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus
Omayma A Ragab AboZaid1, Mohamed K Mahfouz1, Omneia M Abdel Hammed1
1Department of Biochemistry, Benha University, Egypt.
Insights
Treatment with Sofosbuvir and Ribavirin significantly improved liver function and antioxidant profiles in Hepatitis C virus patients. This combination therapy offers a promising approach for managing liver damage caused by the Hepatitis C virus.
Area of Science:
- Hepatology
- Virology
- Biochemistry
Background:
- Hepatitis C virus (HCV) infection is a major global health concern, causing significant liver damage and contributing to morbidity and mortality.
- Effective antiviral therapies are crucial for managing HCV and preventing its long-term consequences.
Purpose of the Study:
- To evaluate the impact of combined Sofosbuvir and Ribavirin therapy on liver function and antioxidant status in patients with Hepatitis C virus infection.
Main Methods:
- A study involving 30 Hepatitis C virus patients and 10 healthy volunteers was conducted.
- Liver function tests and antioxidant profiles were assessed before and after treatment with Sofosbuvir and Ribavirin.
Main Results:
- Treatment led to a significant decrease in elevated liver enzymes (ALT, AST, ALP), bilirubin, and AFP.
- Significant improvements were observed in antioxidant enzyme activities, including glutathione peroxidase, catalase, and superoxide dismutase.
- Levels of L-Malondialdhyde, albumin, and total protein also showed significant changes indicating improved liver health.
Conclusions:
- Combination therapy with Sofosbuvir and Ribavirin effectively improves liver function parameters in Hepatitis C virus patients.
- This treatment regimen also enhances the body's antioxidant defense system, mitigating oxidative stress associated with HCV infection.
Abstract:
Hepatitis C virus is an infectious pathogen affecting thousands of people causing great damage to the liver and consider an important cause of morbidity and mortality in developing countries. This research was conducted on 30 patients infected with hepatitis C virus and 10 control normal volunteers after taking consent of them in order to evaluate the liver function and antioxidants profile after treatment with combination of Sofosbuvir and Ribaverin in hepatitis C virus patients. The results showed significant reduction of elevated levels of L-Malondialdhyde, Alanine Aminotrasferase, Aspartate Aminotrasferase, Alkaline Phosphatase, Albumin, Total protein, Total bilirubin and α-fetoprotein mean while significant increase in glutathione peroxidase, catalase, superoxide dismutase activity upon treatment with combination of sofosbuvir plus ribavirin. In conclusion, the present finding suggest that, treatment of hepatitis C virus patient with combination of Sofosbuvir and Ribavirin significantly improve liver function parameters and antioxidant profile.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Retrovirus Life Cycles
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Drug Excretion: Influencing Factors

